Lots of disgruntled shareholders voicing disappointment, not with the science which as far as we know is still very hopeful, but with the decimated share price. Now Imagine how the top 20 shareholders must be feeling & what they stand to lose. Sure Hopper, Chong & some others got freebies as part of leading the company, but if IMU fails to provide financial success, the freebies and holdings of other major investors will amount to nothing. Somehow i feel that they will be wanting to find a way to reap the financial rewards and see cancer patients receive better treatments to extend their lives for a little longer.
Name
Shares
Capital
Paul Hopper
409,071,906
5.57%
JP Morgan
283,996,697
3.86%
Citicorp Nominees Pty Limited
266,813,810
3.63%
Mann Family
265,582,609
3.61%
HSBC Custody Nominees (Australia) Limited i
213,532,203
2.91%
Dr Nicolas Smith
118,000,000
1.61%
Netwealth Investments Limited <Wrap Ser Vices A/C>
85,488,611
1.16%
Mi Ok Chong
78,416,666
1.07%
BNP Paribas Noms Pty Ltd
70,407,583
0.96%
National Nominees Pty Ltd
60,113,645
0.82%
UBS Nominees Pty Ltd
50,328,041
0.68%
BNP Paribas Noms Pty Ltd <Ib Au Noms Retail Client>
48,979,324
0.67%
HSBC Custody Nominees (Australia) Limited ii
29,079,510
0.40%
Mr Phillip Wood
25,480,000
0.35%
Sve Capital Pty Ltd <Strategic Vision Unit A/C>
23,000,000
0.31%
Dr Yuman Fong
22,379,032
0.30%
Dr Jen Eckstein
20,738,095
0.28%
Dr Lesley Russell
20,238,095
0.28%
Citicorp Nominees Pty Limited <Colonial First State Inv A/C>
20,230,709
0.28%
Jem Investment Fund Holdings Pty Ltd <Jem Invest Fund Family A/C>
20,000,000
0.27%
IMU Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)